Montreal, February 17, 2026 - Mila is pleased to announce a new partnership with AI4Eyes, a Canadian AI-powered Software as a Medical Device (SaMD) that integrates clinical-grade imaging, diagnostics, treatment and care recommendations into one single platform. This strategic collaboration will focus on accelerating the development of next-generation AI applications in eye care by combining Mila’s world-class expertise in machine learning and deep learning with AI4Eyes’ patented SaMD platform and deep clinical eye care expertise. Together, the partners will advance AI-driven diagnostics, treatment decisions, and care recommendations with meaningful real-world clinical impact.
At Mila, we are dedicated to translating cutting-edge AI research into practical outcomes, said Stéphane Létourneau, Executive Vice-President of Mila. AI4Eyes’ innovative SaMD platform, paired with our leadership in advanced AI, creates a promising foundation for driving forward AI-assisted diagnostic insights and treatment planning in the field of ophthalmology.
Read the full Press Release: https://mila.quebec/en/news/mila-and-ai4eyes-partner-to-advance-ai-innovation-in-ophthalmology